Protopic (Tacrolimus) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 8, 2016 Category: Drugs & Pharmacology Source Type: news
tacrolimus (Prograf, Astagraf XL, Envarsus XR)
Title: tacrolimus (Prograf, Astagraf XL, Envarsus XR)Category: MedicationsCreated: 12/6/1998 12:00:00 AMLast Editorial Review: 9/29/2016 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - September 29, 2016 Category: Nutrition Source Type: news
Prograf (Tacrolimus) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 26, 2016 Category: Drugs & Pharmacology Source Type: news
Envarsus XR (Tacrolimus Extended-release Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 6, 2016 Category: Drugs & Pharmacology Source Type: news
Immunosuppressive medication effectively treats ocular graft-versus-host-disease
A complication associated with bone marrow transplantation, graft-versus-host-disease, occurs when a transplanted immune system attacks certain parts of a host's body, and may cause severe dry eye and damage to the cornea. A clinical trial showed that topical doses of ultra low-dose tacrolimus, an immunosuppressive medication, is equally effective and showed fewer hypertensive side effects in treating ocular symptoms associated with graft-versus-host-disease than methylprednisolone, a steroid medication. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 13, 2016 Category: Science Source Type: news
Immunosuppressive medication effectively treats ocular graft-versus-host-disease
(Massachusetts Eye and Ear Infirmary) A complication associated with bone marrow transplantation, graft-versus-host-disease, occurs when a transplanted immune system attacks certain parts of a host's body, and may cause severe dry eye and damage to the cornea. A clinical trial at Massachusetts Eye and Ear showed that topical doses of ultra low-dose tacrolimus, an immunosuppressive medication, is equally effective and showed fewer hypertensive side effects in treating ocular symptoms associated with graft-versus-host-disease than methylprednisolone, a steroid medication. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 13, 2016 Category: Global & Universal Source Type: news
UCLA study yields the key to effective personalized medicine
This study demonstrated the ability to use a patient’s phenotype to personalize their treatment in an actionable manner without the need for genome profiling,” said Ho, a corresponding author of the study. “We also have shown that PPM can be extended to optimize combination therapy for a wide spectrum of diseases.”
Showing that every patient’s response to medical treatment — for diseases ranging from cancer to infectious diseases, or following an organ transplant — produces a parabola-shaped graph is a landmark advance, Ho said. Among other things, the approach will allow doctors to prescribe the precise...
Source: UCLA Newsroom: Health Sciences - April 6, 2016 Category: Universities & Medical Training Source Type: news
Feature Review: Topical treatments for psoriasis of the scalp
Topical treatments for psoriasis of the scalpWhat are the most effective and safest treatments? ...
Source: Cochrane News and Events - March 4, 2016 Category: Information Technology Authors: mumoquit at cochrane.org Source Type: news
VIDEO: What’s new on atopic dermatitis drugs and cancer concerns?
WAIKOLOA, HAWAII – Topical calcineurin inhibitors’ boxed warnings give many patients and physicians pause over cancer concerns – but a new database analysis may put some minds at ease about the drugs’ use for atopic dermatitis.
“Pimecrolimus and tacrolimus are given topically, not internally –... (Source: Skin and Allergy News)
Source: Skin and Allergy News - February 17, 2016 Category: Dermatology Source Type: news
Common cause for complications after kidney transplantation identified
(University of Basel) The BK polyomavirus often causes complications after kidney transplantation. The research group of Professor Hans H. Hirsch from the Department of Biomedicine at the University of Basel has now been able to show, that the immunosuppressive drug Tacrolimus directly activates the replication of the virus and could thus be responsible for these complications. The American Journal of Transplantation has published the study. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 23, 2015 Category: Infectious Diseases Source Type: news
LEO Pharma to Acquire Global Dermatology Portfolio from Astellas
BALLERUP, Denmark, November 11, 2015 -- (Healthcare Sales & Marketing Network) -- LEO Pharma A/S, a global healthcare company dedicated to helping people achieve healthy skin, and Japanese pharmaceutical company Astellas Pharma Inc. today announced that t... Biopharmaceuticals, Dermatology, AcquisitionsLEO Pharma, Astellas Pharma, Protopic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 11, 2015 Category: Pharmaceuticals Source Type: news
Scientists identify potential birth control 'pill' for men
Two drugs that help suppress the immune system in organ transplant patients may have a future as the long-sought birth control "pill" for men, new research suggests. The drugs – cyclosporine A (also known as CsA) and FK506 (also known as tacrolimus) – are given to transplant recipients to reduce... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - October 1, 2015 Category: Science Authors: Karen Kaplan Source Type: news
Envarsus XR (Tacrolimus Extended-release Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 3, 2015 Category: Drugs & Pharmacology Source Type: news
Tacrolimus Comes Out Tops for Lupus Nephritis (CME/CE)
(MedPage Today) -- Meta-analysis compares the available immunosuppressants. (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - July 25, 2015 Category: Rheumatology Source Type: news
Veloxis's Envarsus XR gets FDA approval to treat kidney transplant patients
Denmark-based Veloxis Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its Envarsus XR (tacrolimus extended-release tablets) to treat kidney transplant patients. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - July 12, 2015 Category: Pharmaceuticals Source Type: news
